Congenital afibrinogenemia

Below you will find more information about Congenital afibrinogenemia from Medigest. If you believe that you are suffering from any of the symptoms of Congenital afibrinogenemia it is important that you obtain an accurate diagnosis from a medical professional to ensure that you obtain the correct medication or treatment for your condition. There are medical conditions that carry similar symptoms associated with Congenital afibrinogenemia and therefore the information provided by Medigest is offered as a guideline only and should never be used in preference to seeking professional medical advice. The information relating to Congenital afibrinogenemia comes from a third party source and Medigest will not be held liable for any inaccuracies relating to the information shown.


Congenital afibrinogenemia is categorized as an extremely rare disorder that involves the inability to produce fibrinogen, an essential element of the blood clotting process. This is considered as an autosomal recessive disorder.


If the medical provider suspects some type of bleeding disorder, several laboratory tests can significantly help in determine the extent and type of disease. Tests that could help in the assessment include PTT, fibrinogen levels, reptilase time, bleeding time, thrombin time and clotting time.


Patients may be give blood transfusion containing plasma or cryoprecipitate, or the blood that contains the concentrated form of fibrinogen. Patients with such condition is also required to be have hepatitis B vaccine as in condition tend to increase the risk of contracting hepatitis due to the transfusion of blood.

Symptoms and Signs

The medical symptoms that can be associated with congenital afibrinogenemia includes bleeding umbilical cord , bruises, hematomas, hemopthysis, blood in the urine, hemorrhage in central nervous system, excessive bleeding after an injury, nosebleed, impaired blood clotting, prolonged bleeding time.


This rare disorder is primarily caused by an atypical gene that has been passed on to the child from both parents. This will result to either oa defect in the proper function of available fibrinogen, or lack of fibrinogen in the body. This condition is known to occur in both sexes and primary candidates and people from a family with a history of bleeding.

Discuss Congenital afibrinogenemia in our forums

Discuss Congenital afibrinogenemia with other members of Medigest in our forums.